Zhang et al has previously shown that EBV can modify p53 protein expression [8] , therefore we postulated that EBV persistence in pulmonary epithelial cells may modify epithelial cell repair and apoptosis in IPF patients.
The object of this study was to identify whether both p53 expression (wild and mutant) and EBV persistence existed in the epithelial cells of lung tissue from IPF patients compared to controls.
METHODS
Fourteen archival lung biopsies from IPF patients were randomly selected for the study ( 12 from open lung biopsies (OLB), 2 from lung removed at transplantation).
The lung tissue were fixed in buffered formalin and stained with haemotoxylin and eosin. These biopsies were reviewed by a pulmonary histopathologist (PSH) to confirm patterns consistent with the usual interstitial pneumonia (UIP) form of IPF, and to exclude other causes of pulmonary fibrosis including non-specific interstitial pneumonia (NSIP) and desquamative interstitial pneumonia (DIP). Histological features on biopsy examined for were: 1) A variegated picture of fibrosis, inflammation and normal lung.
2) Exclusion of evidence to suggest another pathology (e.g. asbestos bodies, granuloma etc.)
3) A tendency for pleural and sub-pleural based distribution of fibrosis.
Nineteen patients who underwent pneumonectomies or OLB for pulmonary pathology were used as controls (11 OLB, 3 from lung removed at transplantation and 5 from pneumonectomy or lobectomy performed for lung cancer).
OLB were performed either by a VATS procedure or by open thoracotomy with the site of operation directed by high-resolution computer tomography (HRCT). In those control lung specimens where the primary diagnosis was cancer, lung tissue away from the malignant lesion was used for the study. The lung tissues were examined for the presence of p53 (both mutant and wild-type) using immunohistochemisitry, while EBV was detected by both PCR and immunohistochemisitry. The lung specimens were coded and assessed blind for the presence of p53 and EBV by the histopathologist (PSH).
Immunohistochemistry for p53:
Using paraffin preserved lung tissue 5µm sections were cut. These were dried overnight in an incubator at 37°C and then at 56°C for 30 minutes. The sections were dewaxed using xylene and dehydrated by bringing to absolute alcohol. Staining of the p53 employed a streptavidin peroxidase technique (duet, DAKO) according to the manufacturers' instructions using DAB (3, Immunohistochemistry for EBV was performed as described in a previous study [7] : In each case, 5µm sections were analysed for the presence of the EBV productive cycle by using monoclonal antibodies specific for the EBV structural antigen gp350/220 and VCA. Sections were first incubated at 4°C overnight in a solution of 20% (w/v) bovine serum albumin to block non-specific binding of antibodies.
Staining for EBV lytic cycle antigens and cellular antigen was performed using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturers protocol. Primary antisera were mouse monoclonal reagents including; anti-EBV membrane antigen gp340/220; anti-EBV VCA (MAB 817;
Chemicon International Temecula, California USA); anti-epithelial membrane antigen 6 EMA (M613; dakopatts) anti-CD20, a pan B cell antibody (M755; Dakopatts).
Purified anti-gp 340/220 was used at a concentration of 10ug/ml and anti-VCA was used at a 1:400 dilution. To assess the specificities of the reagents used, reaction against an EBV positive B-cell line B95-8 and EBV-negative B cell line BL41 were used as control. Antigens expressed during the latent phase of EBV life cycle (LMP)
were not studied.
PCR for EBV was performed as previously described [7] : DNA was extracted from 5µm sections that were serially adjacent to those analysed by IHC using Qiamp tissue kits (Qiagen). Control DNA was extracted from the B lymphocyte cell lines AM [8] (EBV-positive) and BL41 [9] (EBV-negative). Pilot studies were performed to analyse the ability of extracted DNA to be amplified by PCR using primers specific for the human p53 gene [10] . This indicated that amplifiable DNA was best obtained if proteinase K digestion of the sample was extended from 12h to 5 days. Amplifiable DNA (100ng) was subjected to nested PCR analysis using oligonucleotide primers specific for EBV and recombinant Taq DNA polymerase (Gibco/BRL). The first round of PCR used the primers 5'-GGTCCCGTAGTGACAACTATGCTG and 5'-GAGTGCACCACAGCCAACTCCATG at an annealing temperature of 60 o C for 40 cycles as described by Lees et al [11] . The second (nested) round of PCR used the cycles. PCR products were electrophoresed through 2% agarose gels and DNA visualised by ethidium bromide staining. Molecular weight determinations were made using the 1Kb ladder (Gibco/BRL). Positive signal for EBV yielded a 284bp
product. Limiting dilution of a known amount of cloned target DNA showed that the 7 PCR was sensitive to one copy of EBV DNA. Sections were randomised, analysed by PCR blind and the results decoded subsequently.
STATISTICS
The demographic data was compared using a non-parametric statistical analysis (Mann-Whitney U test). EBV and p53 staining in the IPF and control patients were compared using the Chi-squared test with Yates' correction. To determine if there was a statistical relationship between EBV and p53 positivity crosstabs was used with kappa correction. The SPSS package was used for the statistical calculations.
RESULTS
The demographics of the patients studied were closely matched for age and sex ( 
DISCUSSION:
This study suggests that a potential relationship exist between p53 and EBV in IPF patients providing a possible mechanism by which EBV may contribute to epithelial cell injury. Both wild p53 staining and EBV positivity were localised to the epithelial cell layer of IPF patients. However a statistical correlation between p53 staining and EBV was not established.
This data shows that wild p53 expression occurs more frequently than the mutant p53 in IPF patients, which is consistent with the findings of Kuwano and colleagues. In shown by Zhang et al [14] . The role of the BZLF-1 protein is to facilitate the propagation of EBV in the host by interfering with the regulation of the cell cycle.
Such an action has led to the proposed tumourigenicity effect of EBV [14] , although in EBV-related malignancies such as Burkitt's lymphoma there is no relationship between EBV and p53 [14] . In addition Szekely et al have suggested that the EBV leader protein expressed during latency, EBNA-5 (EBV nuclear antigen 5) can also interact with p53 [15] . In this study they found that the EBNA-5 protein binds with p53 resulting in an immunoprecpitate. However, it is not known whether p53 function is affected by this particular interaction. Gan et al has shown that ZEBRA does not affect mutant p53 and functions only in the presence of wild p53 [16] . This study supports the role of a potential interaction between p53 and EBV in IPF patients.
Therefore it is possible that an interaction between EBV proteins and p53 may play a role in the disease progression.
We have not identified p53 staining in the fibroblasts. The abnormal degree of fibrosis implies overactivity of collagen production from fibroblasts, and in patients with LiFraumeni syndrome, examination of fibroblasts show abnormal p53 with resultant prolongation and even immortalisation of fibroblasts [17] . However, the role of p53 on the actions of inflammatory cells and fibroblasts can be indirect through its effects on the epithelium. We believe epithelial cells are critically important effector cells in IPF [3, 4, 18] .
Epithelial cells appear to have a role in normal fibroblast function, as a result of cell to cell interaction. An intact, normally functioning epithelium may be responsible for controlling the release and actions of cytokines present during epithelial repair [18] .
Our data showed that p53 and EBV were both found in the epithelial layer. The consequence is a potential viral mediated inhibition of p53 action (through the expression of ZEBRA) on the repair of cells with damaged DNA [14] . The failure of repair to the epithelium could therefore affect the cytokine balance. The potential role of EBV on the actions of p53 is comparable to the effects of human papillomavirus on p53 [19] . Papilloma virus produces proteins that bind with and degrades the p53 protein.
EBV in the course of replication can also interfere with cytokine balance. Klein et al in a study of EBV infected cell lines found that there was increased expression of IL-8, IL-10, TNF-α and TNF-β by these infected cells [20] . The cytokine imbalance induced by EBV together with the impairment of cytokine regulation through the effect on the epithelial layer may initiate the events leading to the development of fibrosis.
This study demonstrates an association between p53 and EBV in the epithelial cells of lung tissue of IPF patents supporting a hypothesis of a viral mediated dysregulation of epithelial cell repair. However, further in vitro studies would be required to determine the precise relationship.
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